Naphazolin (okulär)
Generic name
Naphazolin (okulär)
Brand name
ATC Code
S01GA01
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
After topical application, naphazoline can be systemically absorbed and completely excreted. No further pharmacokinetic data are available. [SmPC Coldphtal]
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Allergic conjunctivitis |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
In children, CNS depression with weakness, insomnia and tremor have been reported uncommonly, especially at high doses. [SmPC Coldophtal]
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
DECONGESTANTS AND ANTIALLERGICS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Other antiallergics | ||
|---|---|---|
| S01GX07 | ||
| S01GX01 | ||
| S01GX06 | ||
| S01GX08 | ||
| S01GX02 | ||
| S01GX09 | ||
References
Changes
Therapeutic Drug Monitoring
Overdose
